Feiyiliu Mixture sensitizes EGFRDel19/T790M/C797S mutant non-small cell lung cancer to osimertinib by attenuating the PRC1/Wnt/EGFR pathway

Jingjing Shi(Qingdao University), Xin Zheng(Qingdao University)
Frontiers in Pharmacology
January 19, 2023
Cited by 13


Related Papers